Publications by authors named "Na'ama Shamir-Stein"
Purpose: SARS-CoV-2 vaccine safety is of major interest worldwide, and transparent information about potential side effects is essential to decrease vaccine hesitancy. The aim of this study was to assess SARS-CoV-2 BNT162b2 vaccine short-term side effects among children aged 5-11 years.
Methods: An observational, cross sectional study of vaccine side-effects using electronic surveys sent to parents one week post administration of BNT162b2 vaccine to their child in a large health maintenance organization in Israel.
BackgroundCOVID-19 vaccine safety is of major interest worldwide, since there is no prior experience with it. Israel was one of the first countries to widely use the Comirnaty vaccine.AimWe aimed to assess the vaccine's short-term side effects directly from a large population and to predict influencing factors for self-reporting side effects.
View Article and Find Full Text PDFBackground: Since July 13, 2021, a third SARS-CoV-2 vaccine BNT162b2 was approved in Israel to immunocompromised and seniors 60 years of age or older. We aimed to evaluate vaccine's reactogenicity.
Methods: A retrospective cohort, using electronic surveys sent to booster vaccine recipients, during July 20-August 10, 2021.
Article Synopsis
- * Survey data provided a more sensitive detection of symptoms compared to electronic records, with common symptoms including fever, cough, and fatigue.
- * Key indicators of COVID-19 included loss of taste and smell occurring three weeks prior to testing, with children experiencing shorter illness duration and some symptoms persisting even after recovery.